RE-Place: A Unique Project Collecting Expertise on New Approach Methodologies Article Swipe
Mieke Van Mulders
,
Nancy Marie Antonia Liodo Missigba
,
Birgit Mertens
,
Vera Rogiers
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.3389/fphar.2022.930148
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.3389/fphar.2022.930148
By applying “New Approach Methodologies (NAMs)” based on innovative technologies such as computer modeling, high throughput testing, omics, and sophisticated cell cultures, the use of experimental animals in the life sciences can be reduced or sometimes even completely avoided. Stimulating NAMs may benefit from a bottom-up approach, i.e., local initiatives mapping the available NAMs and promoting their use. An example of such an initiative in Belgium is the RE-Place project, which collects the available NAMs in one central database, and links this knowledge with the names of experts and research centers. To this extent, a template was created to collect the information of interest in a fast and consistent manner. Based on this template, a web-based application was developed to facilitate the entry of information, which was evaluated in a pilot study by experts in the field of NAMs. After integration of their feedback, a revised version of the RE-Place online tool was launched to the public. Aspects such as user-friendliness, quality of submitted information, protection of personal data and Intellectual Property (IP) rights were all considered in the development process. Hurdles like incentives for collaboration were also taken into account. Information submitted with the online tool is directly integrated in the RE-Place open access database. By consulting the database, scientists from various disciplines can easily identify the different types of NAMs and the experts using them in Belgium. As such, the RE-Place database contributes to building trust in the use of NAMs and stimulating their use and regulatory uptake.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fphar.2022.930148
- https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdf
- OA Status
- gold
- Cited By
- 2
- References
- 12
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4283398902
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4283398902Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fphar.2022.930148Digital Object Identifier
- Title
-
RE-Place: A Unique Project Collecting Expertise on New Approach MethodologiesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-06-22Full publication date if available
- Authors
-
Mieke Van Mulders, Nancy Marie Antonia Liodo Missigba, Birgit Mertens, Vera RogiersList of authors in order
- Landing page
-
https://doi.org/10.3389/fphar.2022.930148Publisher landing page
- PDF URL
-
https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdfDirect OA link when available
- Concepts
-
Computer science, Incentive, World Wide Web, Process (computing), Field (mathematics), Intellectual property, Quality (philosophy), Data science, Knowledge management, Operating system, Epistemology, Mathematics, Pure mathematics, Economics, Philosophy, MicroeconomicsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
12Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4283398902 |
|---|---|
| doi | https://doi.org/10.3389/fphar.2022.930148 |
| ids.doi | https://doi.org/10.3389/fphar.2022.930148 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35814243 |
| ids.openalex | https://openalex.org/W4283398902 |
| fwci | 0.6070047 |
| type | article |
| title | RE-Place: A Unique Project Collecting Expertise on New Approach Methodologies |
| biblio.issue | |
| biblio.volume | 13 |
| biblio.last_page | 930148 |
| biblio.first_page | 930148 |
| topics[0].id | https://openalex.org/T12281 |
| topics[0].field.id | https://openalex.org/fields/34 |
| topics[0].field.display_name | Veterinary |
| topics[0].score | 0.9968000054359436 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3404 |
| topics[0].subfield.display_name | Small Animals |
| topics[0].display_name | Animal testing and alternatives |
| topics[1].id | https://openalex.org/T11190 |
| topics[1].field.id | https://openalex.org/fields/22 |
| topics[1].field.display_name | Engineering |
| topics[1].score | 0.9927999973297119 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2204 |
| topics[1].subfield.display_name | Biomedical Engineering |
| topics[1].display_name | 3D Printing in Biomedical Research |
| topics[2].id | https://openalex.org/T11663 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9915000200271606 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Viral Infectious Diseases and Gene Expression in Insects |
| funders[0].id | https://openalex.org/F4320318001 |
| funders[0].ror | |
| funders[0].display_name | Région de Bruxelles-Capitale |
| funders[1].id | https://openalex.org/F4320327336 |
| funders[1].ror | |
| funders[1].display_name | Vlaamse regering |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| concepts[0].id | https://openalex.org/C41008148 |
| concepts[0].level | 0 |
| concepts[0].score | 0.602887749671936 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[0].display_name | Computer science |
| concepts[1].id | https://openalex.org/C29122968 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5675731301307678 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1414816 |
| concepts[1].display_name | Incentive |
| concepts[2].id | https://openalex.org/C136764020 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5387275218963623 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q466 |
| concepts[2].display_name | World Wide Web |
| concepts[3].id | https://openalex.org/C98045186 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5335156917572021 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q205663 |
| concepts[3].display_name | Process (computing) |
| concepts[4].id | https://openalex.org/C9652623 |
| concepts[4].level | 2 |
| concepts[4].score | 0.48765861988067627 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q190109 |
| concepts[4].display_name | Field (mathematics) |
| concepts[5].id | https://openalex.org/C34974158 |
| concepts[5].level | 2 |
| concepts[5].score | 0.44683295488357544 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q131257 |
| concepts[5].display_name | Intellectual property |
| concepts[6].id | https://openalex.org/C2779530757 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4210273027420044 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1207505 |
| concepts[6].display_name | Quality (philosophy) |
| concepts[7].id | https://openalex.org/C2522767166 |
| concepts[7].level | 1 |
| concepts[7].score | 0.41735103726387024 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2374463 |
| concepts[7].display_name | Data science |
| concepts[8].id | https://openalex.org/C56739046 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3525508642196655 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q192060 |
| concepts[8].display_name | Knowledge management |
| concepts[9].id | https://openalex.org/C111919701 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q9135 |
| concepts[9].display_name | Operating system |
| concepts[10].id | https://openalex.org/C111472728 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q9471 |
| concepts[10].display_name | Epistemology |
| concepts[11].id | https://openalex.org/C33923547 |
| concepts[11].level | 0 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q395 |
| concepts[11].display_name | Mathematics |
| concepts[12].id | https://openalex.org/C202444582 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q837863 |
| concepts[12].display_name | Pure mathematics |
| concepts[13].id | https://openalex.org/C162324750 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[13].display_name | Economics |
| concepts[14].id | https://openalex.org/C138885662 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[14].display_name | Philosophy |
| concepts[15].id | https://openalex.org/C175444787 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q39072 |
| concepts[15].display_name | Microeconomics |
| keywords[0].id | https://openalex.org/keywords/computer-science |
| keywords[0].score | 0.602887749671936 |
| keywords[0].display_name | Computer science |
| keywords[1].id | https://openalex.org/keywords/incentive |
| keywords[1].score | 0.5675731301307678 |
| keywords[1].display_name | Incentive |
| keywords[2].id | https://openalex.org/keywords/world-wide-web |
| keywords[2].score | 0.5387275218963623 |
| keywords[2].display_name | World Wide Web |
| keywords[3].id | https://openalex.org/keywords/process |
| keywords[3].score | 0.5335156917572021 |
| keywords[3].display_name | Process (computing) |
| keywords[4].id | https://openalex.org/keywords/field |
| keywords[4].score | 0.48765861988067627 |
| keywords[4].display_name | Field (mathematics) |
| keywords[5].id | https://openalex.org/keywords/intellectual-property |
| keywords[5].score | 0.44683295488357544 |
| keywords[5].display_name | Intellectual property |
| keywords[6].id | https://openalex.org/keywords/quality |
| keywords[6].score | 0.4210273027420044 |
| keywords[6].display_name | Quality (philosophy) |
| keywords[7].id | https://openalex.org/keywords/data-science |
| keywords[7].score | 0.41735103726387024 |
| keywords[7].display_name | Data science |
| keywords[8].id | https://openalex.org/keywords/knowledge-management |
| keywords[8].score | 0.3525508642196655 |
| keywords[8].display_name | Knowledge management |
| language | en |
| locations[0].id | doi:10.3389/fphar.2022.930148 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S132108250 |
| locations[0].source.issn | 1663-9812 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1663-9812 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Pharmacology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_lineage_names | Frontiers Media |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.3389/fphar.2022.930148 |
| locations[1].id | pmid:35814243 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in pharmacology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35814243 |
| locations[2].id | pmh:oai:vubissmart:VUBISSMART:2000:160693 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306402573 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | VUBIR (Vrije Universiteit Brussel) |
| locations[2].source.host_organization | https://openalex.org/I13469542 |
| locations[2].source.host_organization_name | Vrije Universiteit Brussel |
| locations[2].source.host_organization_lineage | https://openalex.org/I13469542 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | publishedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | True |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://biblio.vub.ac.be/vubir/replace-a-unique-project-collecting-expertise-on-new-approach-methodologies(cb23f3f2-43b4-432c-8b9f-31a892c3864e).html |
| locations[3].id | pmh:oai:doaj.org/article:d8d22171bb32457c95150757226e8f5c |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Frontiers in Pharmacology, Vol 13 (2022) |
| locations[3].landing_page_url | https://doaj.org/article/d8d22171bb32457c95150757226e8f5c |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:9257167 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | Front Pharmacol |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9257167 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5019069977 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2148-963X |
| authorships[0].author.display_name | Mieke Van Mulders |
| authorships[0].countries | BE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[0].affiliations[0].raw_affiliation_string | Faculty of Medicine and Pharmacy, In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel (VUB), Brussels, Belgium |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210145009 |
| authorships[0].affiliations[1].raw_affiliation_string | SD Chemical and Physical Health Risks, Sciensano, Brussels, Belgium |
| authorships[0].institutions[0].id | https://openalex.org/I4210145009 |
| authorships[0].institutions[0].ror | https://ror.org/04ejags36 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210145009 |
| authorships[0].institutions[0].country_code | BE |
| authorships[0].institutions[0].display_name | Sciensano (Belgium) |
| authorships[0].institutions[1].id | https://openalex.org/I13469542 |
| authorships[0].institutions[1].ror | https://ror.org/006e5kg04 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I13469542 |
| authorships[0].institutions[1].country_code | BE |
| authorships[0].institutions[1].display_name | Vrije Universiteit Brussel |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mieke Van Mulders |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Faculty of Medicine and Pharmacy, In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, SD Chemical and Physical Health Risks, Sciensano, Brussels, Belgium |
| authorships[1].author.id | https://openalex.org/A5050143365 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2767-3806 |
| authorships[1].author.display_name | Nancy Marie Antonia Liodo Missigba |
| authorships[1].countries | BE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[1].affiliations[0].raw_affiliation_string | Faculty of Medicine and Pharmacy, In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel (VUB), Brussels, Belgium |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210145009 |
| authorships[1].affiliations[1].raw_affiliation_string | SD Chemical and Physical Health Risks, Sciensano, Brussels, Belgium |
| authorships[1].institutions[0].id | https://openalex.org/I4210145009 |
| authorships[1].institutions[0].ror | https://ror.org/04ejags36 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210145009 |
| authorships[1].institutions[0].country_code | BE |
| authorships[1].institutions[0].display_name | Sciensano (Belgium) |
| authorships[1].institutions[1].id | https://openalex.org/I13469542 |
| authorships[1].institutions[1].ror | https://ror.org/006e5kg04 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I13469542 |
| authorships[1].institutions[1].country_code | BE |
| authorships[1].institutions[1].display_name | Vrije Universiteit Brussel |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nancy Liodo Missigba |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Faculty of Medicine and Pharmacy, In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel (VUB), Brussels, Belgium, SD Chemical and Physical Health Risks, Sciensano, Brussels, Belgium |
| authorships[2].author.id | https://openalex.org/A5045328245 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8298-9104 |
| authorships[2].author.display_name | Birgit Mertens |
| authorships[2].countries | BE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210145009 |
| authorships[2].affiliations[0].raw_affiliation_string | SD Chemical and Physical Health Risks, Sciensano, Brussels, Belgium |
| authorships[2].institutions[0].id | https://openalex.org/I4210145009 |
| authorships[2].institutions[0].ror | https://ror.org/04ejags36 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210145009 |
| authorships[2].institutions[0].country_code | BE |
| authorships[2].institutions[0].display_name | Sciensano (Belgium) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Birgit Mertens |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | SD Chemical and Physical Health Risks, Sciensano, Brussels, Belgium |
| authorships[3].author.id | https://openalex.org/A5008668373 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0635-7740 |
| authorships[3].author.display_name | Vera Rogiers |
| authorships[3].countries | BE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I13469542 |
| authorships[3].affiliations[0].raw_affiliation_string | Faculty of Medicine and Pharmacy, In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel (VUB), Brussels, Belgium |
| authorships[3].institutions[0].id | https://openalex.org/I13469542 |
| authorships[3].institutions[0].ror | https://ror.org/006e5kg04 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I13469542 |
| authorships[3].institutions[0].country_code | BE |
| authorships[3].institutions[0].display_name | Vrije Universiteit Brussel |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Vera Rogiers |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Faculty of Medicine and Pharmacy, In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel (VUB), Brussels, Belgium |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | RE-Place: A Unique Project Collecting Expertise on New Approach Methodologies |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12281 |
| primary_topic.field.id | https://openalex.org/fields/34 |
| primary_topic.field.display_name | Veterinary |
| primary_topic.score | 0.9968000054359436 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3404 |
| primary_topic.subfield.display_name | Small Animals |
| primary_topic.display_name | Animal testing and alternatives |
| related_works | https://openalex.org/W1998011869, https://openalex.org/W4213209802, https://openalex.org/W4298146316, https://openalex.org/W2236267847, https://openalex.org/W631166945, https://openalex.org/W4282843169, https://openalex.org/W3021519232, https://openalex.org/W2391064200, https://openalex.org/W4313241434, https://openalex.org/W3176706560 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 5 |
| best_oa_location.id | doi:10.3389/fphar.2022.930148 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S132108250 |
| best_oa_location.source.issn | 1663-9812 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1663-9812 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Pharmacology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_lineage_names | Frontiers Media |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Pharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fphar.2022.930148 |
| primary_location.id | doi:10.3389/fphar.2022.930148 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S132108250 |
| primary_location.source.issn | 1663-9812 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1663-9812 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Pharmacology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_lineage_names | Frontiers Media |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/articles/10.3389/fphar.2022.930148/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.3389/fphar.2022.930148 |
| publication_date | 2022-06-22 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2413595704, https://openalex.org/W3166618611, https://openalex.org/W6927218659, https://openalex.org/W2465700552, https://openalex.org/W3160569813, https://openalex.org/W4255359625, https://openalex.org/W913457967, https://openalex.org/W2898688604, https://openalex.org/W2125987139, https://openalex.org/W3095344728, https://openalex.org/W3173735040, https://openalex.org/W2438581320 |
| referenced_works_count | 12 |
| abstract_inverted_index.a | 44, 94, 105, 114, 129, 144 |
| abstract_inverted_index.An | 58 |
| abstract_inverted_index.As | 229 |
| abstract_inverted_index.By | 0, 206 |
| abstract_inverted_index.To | 91 |
| abstract_inverted_index.an | 62 |
| abstract_inverted_index.as | 11, 159 |
| abstract_inverted_index.be | 32 |
| abstract_inverted_index.by | 132 |
| abstract_inverted_index.in | 27, 64, 75, 104, 128, 134, 177, 200, 227, 238 |
| abstract_inverted_index.is | 66, 197 |
| abstract_inverted_index.of | 24, 60, 86, 102, 123, 137, 141, 147, 162, 166, 220, 241 |
| abstract_inverted_index.on | 7, 111 |
| abstract_inverted_index.or | 34 |
| abstract_inverted_index.to | 98, 119, 154, 235 |
| abstract_inverted_index.all | 175 |
| abstract_inverted_index.and | 18, 54, 79, 88, 107, 169, 222, 243, 247 |
| abstract_inverted_index.can | 31, 214 |
| abstract_inverted_index.for | 184 |
| abstract_inverted_index.may | 41 |
| abstract_inverted_index.one | 76 |
| abstract_inverted_index.the | 22, 28, 51, 67, 72, 84, 100, 121, 135, 148, 155, 178, 194, 201, 208, 217, 223, 231, 239 |
| abstract_inverted_index.use | 23, 240, 246 |
| abstract_inverted_index.was | 96, 117, 126, 152 |
| abstract_inverted_index.(IP) | 172 |
| abstract_inverted_index.NAMs | 40, 53, 74, 221, 242 |
| abstract_inverted_index.also | 187 |
| abstract_inverted_index.cell | 20 |
| abstract_inverted_index.data | 168 |
| abstract_inverted_index.even | 36 |
| abstract_inverted_index.fast | 106 |
| abstract_inverted_index.from | 43, 211 |
| abstract_inverted_index.high | 14 |
| abstract_inverted_index.into | 189 |
| abstract_inverted_index.life | 29 |
| abstract_inverted_index.like | 182 |
| abstract_inverted_index.open | 203 |
| abstract_inverted_index.such | 10, 61, 158 |
| abstract_inverted_index.them | 226 |
| abstract_inverted_index.this | 81, 92, 112 |
| abstract_inverted_index.tool | 151, 196 |
| abstract_inverted_index.use. | 57 |
| abstract_inverted_index.were | 174, 186 |
| abstract_inverted_index.with | 83, 193 |
| abstract_inverted_index.After | 139 |
| abstract_inverted_index.Based | 110 |
| abstract_inverted_index.NAMs. | 138 |
| abstract_inverted_index.based | 6 |
| abstract_inverted_index.entry | 122 |
| abstract_inverted_index.field | 136 |
| abstract_inverted_index.i.e., | 47 |
| abstract_inverted_index.links | 80 |
| abstract_inverted_index.local | 48 |
| abstract_inverted_index.names | 85 |
| abstract_inverted_index.pilot | 130 |
| abstract_inverted_index.study | 131 |
| abstract_inverted_index.such, | 230 |
| abstract_inverted_index.taken | 188 |
| abstract_inverted_index.their | 56, 142, 245 |
| abstract_inverted_index.trust | 237 |
| abstract_inverted_index.types | 219 |
| abstract_inverted_index.using | 225 |
| abstract_inverted_index.which | 70, 125 |
| abstract_inverted_index.access | 204 |
| abstract_inverted_index.easily | 215 |
| abstract_inverted_index.omics, | 17 |
| abstract_inverted_index.online | 150, 195 |
| abstract_inverted_index.rights | 173 |
| abstract_inverted_index.“New | 2 |
| abstract_inverted_index.Aspects | 157 |
| abstract_inverted_index.Belgium | 65 |
| abstract_inverted_index.Hurdles | 181 |
| abstract_inverted_index.animals | 26 |
| abstract_inverted_index.benefit | 42 |
| abstract_inverted_index.central | 77 |
| abstract_inverted_index.collect | 99 |
| abstract_inverted_index.created | 97 |
| abstract_inverted_index.example | 59 |
| abstract_inverted_index.experts | 87, 133, 224 |
| abstract_inverted_index.extent, | 93 |
| abstract_inverted_index.manner. | 109 |
| abstract_inverted_index.mapping | 50 |
| abstract_inverted_index.public. | 156 |
| abstract_inverted_index.quality | 161 |
| abstract_inverted_index.reduced | 33 |
| abstract_inverted_index.revised | 145 |
| abstract_inverted_index.uptake. | 249 |
| abstract_inverted_index.various | 212 |
| abstract_inverted_index.version | 146 |
| abstract_inverted_index.Approach | 3 |
| abstract_inverted_index.Belgium. | 228 |
| abstract_inverted_index.Property | 171 |
| abstract_inverted_index.RE-Place | 68, 149, 202, 232 |
| abstract_inverted_index.account. | 190 |
| abstract_inverted_index.applying | 1 |
| abstract_inverted_index.avoided. | 38 |
| abstract_inverted_index.building | 236 |
| abstract_inverted_index.centers. | 90 |
| abstract_inverted_index.collects | 71 |
| abstract_inverted_index.computer | 12 |
| abstract_inverted_index.database | 233 |
| abstract_inverted_index.directly | 198 |
| abstract_inverted_index.identify | 216 |
| abstract_inverted_index.interest | 103 |
| abstract_inverted_index.launched | 153 |
| abstract_inverted_index.personal | 167 |
| abstract_inverted_index.process. | 180 |
| abstract_inverted_index.project, | 69 |
| abstract_inverted_index.research | 89 |
| abstract_inverted_index.sciences | 30 |
| abstract_inverted_index.template | 95 |
| abstract_inverted_index.testing, | 16 |
| abstract_inverted_index.(NAMs)” | 5 |
| abstract_inverted_index.approach, | 46 |
| abstract_inverted_index.available | 52, 73 |
| abstract_inverted_index.bottom-up | 45 |
| abstract_inverted_index.cultures, | 21 |
| abstract_inverted_index.database, | 78, 209 |
| abstract_inverted_index.database. | 205 |
| abstract_inverted_index.developed | 118 |
| abstract_inverted_index.different | 218 |
| abstract_inverted_index.evaluated | 127 |
| abstract_inverted_index.feedback, | 143 |
| abstract_inverted_index.knowledge | 82 |
| abstract_inverted_index.modeling, | 13 |
| abstract_inverted_index.promoting | 55 |
| abstract_inverted_index.sometimes | 35 |
| abstract_inverted_index.submitted | 163, 192 |
| abstract_inverted_index.template, | 113 |
| abstract_inverted_index.web-based | 115 |
| abstract_inverted_index.completely | 37 |
| abstract_inverted_index.considered | 176 |
| abstract_inverted_index.consistent | 108 |
| abstract_inverted_index.consulting | 207 |
| abstract_inverted_index.facilitate | 120 |
| abstract_inverted_index.incentives | 183 |
| abstract_inverted_index.initiative | 63 |
| abstract_inverted_index.innovative | 8 |
| abstract_inverted_index.integrated | 199 |
| abstract_inverted_index.protection | 165 |
| abstract_inverted_index.regulatory | 248 |
| abstract_inverted_index.scientists | 210 |
| abstract_inverted_index.throughput | 15 |
| abstract_inverted_index.Information | 191 |
| abstract_inverted_index.Stimulating | 39 |
| abstract_inverted_index.application | 116 |
| abstract_inverted_index.contributes | 234 |
| abstract_inverted_index.development | 179 |
| abstract_inverted_index.disciplines | 213 |
| abstract_inverted_index.information | 101 |
| abstract_inverted_index.initiatives | 49 |
| abstract_inverted_index.integration | 140 |
| abstract_inverted_index.stimulating | 244 |
| abstract_inverted_index.Intellectual | 170 |
| abstract_inverted_index.experimental | 25 |
| abstract_inverted_index.information, | 124, 164 |
| abstract_inverted_index.technologies | 9 |
| abstract_inverted_index.Methodologies | 4 |
| abstract_inverted_index.collaboration | 185 |
| abstract_inverted_index.sophisticated | 19 |
| abstract_inverted_index.user-friendliness, | 160 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5019069977 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I13469542, https://openalex.org/I4210145009 |
| citation_normalized_percentile.value | 0.61298283 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |